Faisal Alasmari1, Sondra M Seiler2, Tiffany Hink2, Carey-Ann D Burnham3, Erik R Dubberke2. 1. Department of Medicine Department of Medicine, Division of Infectious Diseases, King Fahad Medical City, Riyadh, Saudi Arabia. 2. Department of Medicine. 3. Department of Medicine Department of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri.
Abstract
BACKGROUND: Clostridium difficile infection (CDI) incidence has increased dramatically over the last decade. Recent studies suggest that asymptomatic carriers may be an important reservoir of C. difficile in healthcare settings. We sought to identify the prevalence and risk factors for asymptomatic C. difficile carriage on admission to the hospital. METHODS: Patients admitted to Barnes-Jewish Hospital without diarrhea were enrolled from June 2010 through October 2011. Demographic information and healthcare and medication exposures 90 days prior to admission were collected. Stool specimens or rectal swabs were collected within 48 hours of admission and stored at -30°C until cultured. Clostridium difficile isolates were typed and compared with isolates from patients with CDI. RESULTS: A stool/swab specimen was obtained for 259 enrolled subjects on admission. Two hundred four (79%) were not colonized, 40 (15%) had toxigenic C. difficile (TCD), and 15 (6%) had nontoxigenic C. difficile. There were no differences between TCD-colonized and -uncolonized subjects for age (mean, 56 vs 58 years; P = .46), comorbidities, admission from another healthcare facility (33% vs 24%; P = .23), or recent hospitalization (50% vs 50%; P = .43). There were no differences in antimicrobial exposures in the 90 days prior to admission (55% vs 56%; P = .91). Asymptomatic carriers were colonized with strains similar to strains from patients with CDI, but the relative proportions were different. CONCLUSIONS: There was a high prevalence of TCD colonization on admission. In contrast to past studies, TCD colonization was not associated with recent antimicrobial or healthcare exposures. Additional investigation is needed to determine the role of asymptomatic TCD carriers on hospital-onset CDI incidence.
BACKGROUND:Clostridium difficileinfection (CDI) incidence has increased dramatically over the last decade. Recent studies suggest that asymptomatic carriers may be an important reservoir of C. difficile in healthcare settings. We sought to identify the prevalence and risk factors for asymptomatic C. difficile carriage on admission to the hospital. METHODS:Patients admitted to Barnes-Jewish Hospital without diarrhea were enrolled from June 2010 through October 2011. Demographic information and healthcare and medication exposures 90 days prior to admission were collected. Stool specimens or rectal swabs were collected within 48 hours of admission and stored at -30°C until cultured. Clostridium difficile isolates were typed and compared with isolates from patients with CDI. RESULTS: A stool/swab specimen was obtained for 259 enrolled subjects on admission. Two hundred four (79%) were not colonized, 40 (15%) had toxigenic C. difficile (TCD), and 15 (6%) had nontoxigenic C. difficile. There were no differences between TCD-colonized and -uncolonized subjects for age (mean, 56 vs 58 years; P = .46), comorbidities, admission from another healthcare facility (33% vs 24%; P = .23), or recent hospitalization (50% vs 50%; P = .43). There were no differences in antimicrobial exposures in the 90 days prior to admission (55% vs 56%; P = .91). Asymptomatic carriers were colonized with strains similar to strains from patients with CDI, but the relative proportions were different. CONCLUSIONS: There was a high prevalence of TCD colonization on admission. In contrast to past studies, TCD colonization was not associated with recent antimicrobial or healthcare exposures. Additional investigation is needed to determine the role of asymptomatic TCD carriers on hospital-onset CDI incidence.
Authors: Lars F Westblade; Robin R Chamberland; Duncan MacCannell; Rachel Collins; Erik R Dubberke; W Michael Dunne; Carey-Ann D Burnham Journal: J Clin Microbiol Date: 2012-11-21 Impact factor: 5.948
Authors: Sheila Waslawski; Eugene S Lo; Sarah A Ewing; Vincent B Young; David M Aronoff; Susan E Sharp; Susan M Novak-Weekley; Arthur E Crist; W Michael Dunne; Joan Hoppe-Bauer; Michelle Johnson; Stephen M Brecher; Duane W Newton; Seth T Walk Journal: J Clin Microbiol Date: 2013-04-03 Impact factor: 5.948
Authors: Scott R Curry; Carlene A Muto; Jessica L Schlackman; A William Pasculle; Kathleen A Shutt; Jane W Marsh; Lee H Harrison Journal: Clin Infect Dis Date: 2013-07-23 Impact factor: 9.079
Authors: Surbhi Leekha; Kimberly C Aronhalt; Lynne M Sloan; Robin Patel; Robert Orenstein Journal: Am J Infect Control Date: 2013-05 Impact factor: 2.918
Authors: Amit S Chitnis; Stacy M Holzbauer; Ruth M Belflower; Lisa G Winston; Wendy M Bamberg; Carol Lyons; Monica M Farley; Ghinwa K Dumyati; Lucy E Wilson; Zintars G Beldavs; John R Dunn; L Hannah Gould; Duncan R MacCannell; Dale N Gerding; L Clifford McDonald; Fernanda C Lessa Journal: JAMA Intern Med Date: 2013-07-22 Impact factor: 21.873
Authors: Derrick W Crook; Mark H Wilcox; Tim E A Peto; A Sarah Walker; David W Eyre; Madeleine L Cule; Daniel J Wilson; David Griffiths; Alison Vaughan; Lily O'Connor; Camilla L C Ip; Tanya Golubchik; Elizabeth M Batty; John M Finney; David H Wyllie; Xavier Didelot; Paolo Piazza; Rory Bowden; Kate E Dingle; Rosalind M Harding Journal: N Engl J Med Date: 2013-09-26 Impact factor: 91.245
Authors: Xavier Didelot; David W Eyre; Madeleine Cule; Camilla L C Ip; M Azim Ansari; David Griffiths; Alison Vaughan; Lily O'Connor; Tanya Golubchik; Elizabeth M Batty; Paolo Piazza; Daniel J Wilson; Rory Bowden; Peter J Donnelly; Kate E Dingle; Mark Wilcox; A Sarah Walker; Derrick W Crook; Tim E A Peto; Rosalind M Harding Journal: Genome Biol Date: 2012-12-21 Impact factor: 13.583
Authors: Mark D Gonzalez; Meghan A Wallace; Tiffany Hink; Erik R Dubberke; Carey-Ann D Burnham Journal: Antimicrob Agents Chemother Date: 2015-08-17 Impact factor: 5.191
Authors: Ioannis M Zacharioudakis; Fainareti N Zervou; Elina Eleftheria Pliakos; Panayiotis D Ziakas; Eleftherios Mylonakis Journal: Am J Gastroenterol Date: 2015-07 Impact factor: 10.864
Authors: B Berenger; L Chui; A R Reimer; V Allen; D Alexander; M-C Domingo; D Haldane; L Hoang; P Levett; A MacKeen; D Marcino; C Sheitoyan-Pesant; G Zahariadis Journal: Can Commun Dis Rep Date: 2017-12-07
Authors: Jennie H Kwon; Cristina Lanzas; Kimberly A Reske; Tiffany Hink; Sondra M Seiler; Kerry M Bommarito; Carey-Ann D Burnham; Erik R Dubberke Journal: Infect Control Hosp Epidemiol Date: 2016-10-03 Impact factor: 3.254